-- Seed data for company_research (Prospects)
INSERT INTO company_research (company_name, lead_score, lead_recommendation, summary_for_sales, company_overview, decision_maker_roles, visibility_pain_points, technology_and_logistics_needs, supply_chain_profile, operational_scale, financial_profile, growth_and_initiatives, risk_factors, updated_at) VALUES
('McKesson', 86, 'HIGH PRIORITY', 'Improve DSCSA data integrity — McKesson''s active serialization initiative creates an immediate opening for Decklar''s track and trace capabilities. Lead with compliance ROI and speed to deployment.', 'McKesson Corporation is a Fortune 10 healthcare company that distributes pharmaceuticals and provides health information technology, medical supplies, and care management tools. The company operates one of the largest pharmaceutical distribution networks in North America.', 'Chief Supply Chain Officer, VP of Regulatory Affairs, Director of Serialization and Track and Trace, VP of Pharmacy Operations', 'McKesson faces significant visibility challenges across their pharmaceutical distribution network, particularly with DSCSA compliance deadlines approaching. Current serialization systems are fragmented across facilities, creating data integrity risks.', 'Active investment in serialization infrastructure, evaluating cloud-based track and trace solutions, modernizing warehouse management systems across 40+ distribution centers.', 'Multi-tier distribution network serving 40,000+ pharmacies, hospitals, and clinics. Partners include major pharmaceutical manufacturers and regional healthcare networks.', '40+ distribution centers across North America, 78,000 employees, processing 2.2 billion prescription units annually.', 'Annual revenue: $308 billion (FY2024), 4.2 percent YoY growth. Strong cash flow position with $3.1 billion in operating cash flow.', 'Expanding specialty drug distribution capabilities, new partnership with regional hospital network adding 18 facilities, investing $200M in supply chain technology modernization.', 'Regulatory compliance deadlines (DSCSA 2024), potential supply chain disruptions, competitive pressure from Amazon Pharmacy.', NOW() - INTERVAL ''4 hours''),
('Cardinal Health', 82, 'HIGH PRIORITY', 'Cardinal Health''s expansion into specialty pharmaceuticals and recent CVS partnership extension signal strong growth momentum. Their serialization readiness initiative aligns perfectly with Decklar''s capabilities.', 'Cardinal Health is a global, integrated healthcare services and products company providing customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices worldwide.', 'Chief Operating Officer, VP of Supply Chain Innovation, Director of Compliance and Regulatory Affairs, VP of Distribution Operations', 'Visibility gaps in specialty pharmaceutical cold chain logistics, limited real-time tracking across multi-modal transportation, compliance monitoring challenges across 30+ distribution facilities.', 'Implementing advanced cold chain monitoring, evaluating AI-powered demand forecasting, upgrading serialization infrastructure to meet enhanced DSCSA requirements.', 'Operates 30+ distribution centers, serves 60,000+ pharmacies and healthcare facilities, manages complex cold chain logistics for specialty pharmaceuticals.', '30+ distribution centers, 46,500 employees, $210 billion in annual product distribution volume.', 'Annual revenue: $181 billion (FY2024), 6.1 percent YoY growth, strong margins in specialty pharmaceutical segment.', 'New distribution center opening in Ohio (Q2 2026), CVS Health partnership expanded to 3 new states, acquiring regional specialty pharmacy distributor.', 'Cold chain compliance risks, increasing competition in specialty pharma distribution, regulatory scrutiny on drug pricing.', NOW() - INTERVAL ''3 hours''),
('AmerisourceBergen', 78, 'MEDIUM', 'AmerisourceBergen''s focus on specialty distribution and recent technology investments create an opportunity for Decklar to support their serialization and compliance initiatives.', 'AmerisourceBergen is one of the largest pharmaceutical sourcing and distribution services companies, helping both healthcare providers and pharmaceutical manufacturers improve patient access to products and enhance patient care.', 'SVP of Operations, VP of Technology and Innovation, Director of Regulatory Compliance, Chief Supply Chain Officer', 'Challenges with end-to-end visibility in specialty pharmaceutical distribution, serialization data aggregation across disparate systems, real-time compliance monitoring gaps.', 'Investing in blockchain for supply chain transparency, upgrading warehouse automation, implementing predictive analytics for inventory optimization.', 'Network of 25+ distribution centers, serves 50,000+ healthcare providers, strong presence in specialty pharmaceutical distribution.', '25+ distribution centers, 41,000 employees, handles 20 percent of U.S. pharmaceutical distribution.', 'Annual revenue: $262 billion (FY2024), 8.3 percent YoY growth driven by specialty pharma segment.', 'Launching new specialty distribution hub in Texas, partnership with major oncology network, $150M technology modernization program.', 'DSCSA compliance deadlines, integration challenges from recent acquisitions, margin pressure in generic drug distribution.', NOW() - INTERVAL ''1 day''),
('Walgreens Boots Alliance', 71, 'MEDIUM', 'Walgreens'' retail pharmacy network modernization and supply chain optimization initiatives present opportunities for track and trace solutions, especially for their specialty pharmacy division.', 'Walgreens Boots Alliance is an integrated healthcare, pharmacy and retail leader serving millions of customers and patients every day, with a 170-year heritage of caring for communities.', 'Chief Supply Chain Officer, VP of Pharmacy Operations, Director of Compliance, SVP of Retail Operations', 'Limited visibility between retail pharmacies and central distribution, challenges tracking specialty medications across the last mile, compliance monitoring across 9,000+ retail locations.', 'Modernizing pharmacy management systems, implementing automated dispensing technology, upgrading supply chain visibility tools across retail network.', 'Operates 9,000+ retail pharmacies, central distribution network serving all locations, growing specialty pharmacy and mail-order operations.', '9,000+ retail locations, 315,000 employees, filling 1 billion+ prescriptions annually.', 'Annual revenue: $139 billion (FY2024), facing margin pressure but investing heavily in healthcare services transformation.', 'Expanding specialty pharmacy services, partnering with VillageMD for in-store clinics, closing 150 underperforming stores while opening healthcare-focused locations.', 'Retail pharmacy margin compression, competition from mail-order and online pharmacies, regulatory compliance costs.', NOW() - INTERVAL ''2 days'')
ON CONFLICT (company_name) DO NOTHING;

-- Seed data for decklar_customers
INSERT INTO decklar_customers (company_name, health_score, account_tier, industry, strategic_summary, latest_news_summary, funding_or_financial_moves, leadership_changes, expansion_or_contracts, regulatory_compliance_updates, updated_at) VALUES
('Cardinal Health', 78, 'ENTERPRISE', 'Healthcare Distribution', 'Cardinal Health is in active expansion mode — new distribution center openings and the CVS partnership extension signal strong account health. The upcoming FDA serialization deadline review is an opportunity to deepen Decklar''s engagement.', 'Cardinal Health announced Q1 2026 earnings with revenue up 6.1 percent year-over-year. The company also announced a new distribution center in Ohio scheduled to open in Q2 2026, expanding their specialty pharmaceutical capabilities by 15 percent.', 'Q1 2026 earnings: $181B annual revenue, 6.1 percent YoY growth. Acquiring regional specialty pharmacy distributor for $420M (expected close Q3 2026).', 'No recent leadership changes. Current CEO Jason Hollar reaffirmed commitment to specialty pharma growth strategy in recent earnings call.', 'New distribution center opening in Columbus, Ohio (Q2 2026). CVS Health partnership expanded to Connecticut, Rhode Island, and Vermont. New contract with regional hospital network covering 45 facilities.', 'Successfully completed Phase 1 DSCSA compliance audit. Preparing for enhanced serialization requirements effective November 2026.', NOW() - INTERVAL ''3 hours''),
('Express Scripts', 85, 'ENTERPRISE', 'Pharmacy Benefits Management', 'Express Scripts continues to demonstrate strong account health with technology investments and network expansion. Their focus on specialty pharmacy and digital health creates opportunities for enhanced supply chain visibility solutions.', 'Express Scripts announced a major technology modernization initiative, investing $300M in supply chain visibility and patient engagement platforms. The company also expanded their specialty pharmacy network with 5 new facilities.', 'Parent company Cigna reported strong PBM segment growth. Express Scripts contributing $120B in annual revenue. No major M&A activity but significant organic investment in technology infrastructure.', 'Appointed new Chief Technology Officer, Dr. Sarah Chen, formerly VP of Digital Health at CVS Health. Focus on AI-powered formulary management and supply chain optimization.', 'Opening 5 new specialty pharmacy facilities across the U.S. New partnership with telehealth provider covering 2M members. Expanding mail-order capacity by 30 percent.', 'Implementing enhanced controlled substance tracking systems. Participating in FDA pilot program for electronic prior authorization.', NOW() - INTERVAL ''5 hours''),
('Kroger Pharmacy', 72, 'MID-MARKET', 'Retail Pharmacy', 'Kroger Pharmacy shows stable health with steady growth in retail pharmacy services. Recent investments in digital prescription management and supply chain technology align well with Decklar''s capabilities.', 'Kroger announced expansion of their pharmacy services across 150 additional retail locations. The company is also piloting a new digital prescription management system in 500 stores.', 'Parent company Kroger reported $148B in annual revenue. Pharmacy segment growing at 4.2 percent annually. Investing $50M in pharmacy technology upgrades across the network.', 'No significant pharmacy leadership changes. Current VP of Pharmacy Operations leading digital transformation initiative.', 'Adding pharmacy services to 150 stores in 2026. Expanding specialty pharmacy offerings in existing locations. New partnership with local health systems for clinical services.', 'Completed state pharmacy board compliance audits across all locations. Implementing enhanced controlled substance monitoring systems.', NOW() - INTERVAL ''1 day'')
ON CONFLICT (company_name) DO NOTHING;

-- Seed data for company_notes
INSERT INTO company_notes (note_text, author_name, company_name, company_type, created_at) VALUES
('Called Sarah Mitchell (VP Pharmacy Ops). She confirmed they are evaluating DSCSA vendors in Q2. Asked to follow up after their board meeting in March.', 'James Sullivan', 'McKesson', 'Prospect', NOW() - INTERVAL ''2 days''),
('LinkedIn connection sent to Director of Serialization.', 'Anika Rao', 'McKesson', 'Prospect', NOW() - INTERVAL ''4 days''),
('Great call with procurement team. They are very interested in our compliance automation features. Sending proposal next week.', 'James Sullivan', 'Cardinal Health', 'Customer', NOW() - INTERVAL ''1 day''),
('Attended their quarterly business review. Health score remains strong. Discussed expansion to 3 additional distribution centers.', 'Michael Torres', 'Cardinal Health', 'Customer', NOW() - INTERVAL ''3 days''),
('Initial outreach email sent to Chief Supply Chain Officer. No response yet.', 'Anika Rao', 'AmerisourceBergen', 'Prospect', NOW() - INTERVAL ''5 days'');
